Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase III trial of intranasal dexmedetomidine in patients with acute postoperative pain.

Next Previous
Trial Profile

Phase III trial of intranasal dexmedetomidine in patients with acute postoperative pain.

Status: Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 29 Oct 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dexmedetomidine (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Sponsors Societal CDMO

    • Most Recent Events

    • 26 Oct 2015 According to Recro Pharma media release, the company has decided not to continue with the clinical program for Dex-IN in post operative pain after feedback from FDA on the phase II efficacy and safety data. It intends to pursue a phase II program in peri-procedural pan instead.
    • 26 Oct 2015 Status changed from planning to withdrawn prior to enrolment, based on the information in the Recro Pharma media release.
    • 27 Mar 2015 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top